Author: OurCrowd

[OurCrowd in The Jerusalem Post] What are the top 10 post-pandemic tech trends?

Industries and societies around the world have reset their priorities, and a range of new technologies is coming into focus. On Tuesday, July 13, at 7 p.m. Israel time (12:00 PM Eastern time), OurCrowd, the Jerusalem-based investment platform for startups, early-stage companies, and venture funds, will host “Top 10 Post-Pandemic Tech Trends,” an online event that will highlight the key technology trends and developments as the world emerges from the pandemic. Read...

Read More

Newsletter: Car and motorbike safety + Sustaining Israel’s startups

Startup of the Week: Leading carmaker joins Foretellix round ‘I would have been splattered if not for Ride Vision’ July 13: Top 10 Post-Pandemic Tech Trends What’s driving the flood of Israeli IPOs? Securing the base of Israel’s high-tech pyramid TytoCare: Helping children’s healthcare from Leeds to Mexico Superpedestrian’s LINK e-scooters ride into Baltimore Zebra Medical Vision wins landmark approval for AI radiology code Zzapp Malaria wins $250,000 Cisco Global Problem Solver Prize Cisco’s acquisition of Kenna enhances hybrid work security TetaVi selected for Microsoft for Startups Ro Health acquires at-home testing startup Kit Introductions More than 2,700 high-tech jobs worldwide Startup of the Week:Foretellix: Leading European carmaker joins round Safety is a key issue for autonomous cars. The industry has just now begun to establish software testing standards and languages for verifying autonomous vehicles because road tests take far too much time and money. Foretellix is setting the industry standard in safety testing for autonomous vehicles, with a platform that can validate automated driving systems software in hundreds of millions of scenarios. Foretellix is expanding its Series B...

Read More

[SaNOtize in RepublicWorld.com] Glenmark To Conduct Phase III Trials Of Nasal Spray Which It Claims Can Treat COVID-19

In a major development in the COVID medicine field, Glenmark Pharmaceuticals said that it will be conducting a Phase III trial on a nasal spray claiming to be effective in the treatment of COVID-19. Earlier last week, the company had sought emergency approval for the import and marketing of the nasal spray from the drug regulator. The pharma company has now been recommended to hold phase III trials by the authorities. Register...

Read More